12993 studies found for:    Canada
Show Display Options
Rank Status Study
1 Completed Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
Conditions: Cachexia;   Lymphoma;   Lymphoproliferative Disorder;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Dietary Supplement: Juven;   Dietary Supplement: Non-Juven Supplement
2 Terminated Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Condition: Chronic Plaque Psoriasis
Intervention: Drug: Amevive exposure
3 Recruiting A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: CP-690,550
4 Completed Prevention of Asthma Relapse After Discharge From Emergency
Condition: Asthma
Intervention: Drug: Budesonide/formoterol
5 Completed Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: cyproterone acetate;   Drug: flutamide;   Drug: goserelin;   Drug: leuprolide acetate;   Drug: nilutamide
6 Unknown  Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy
Condition: Ovarian Cancer
Interventions: Drug: carboplatin;   Drug: gemcitabine hydrochloride
7 Completed
Has Results
An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy
Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
8 Completed
Has Results
Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
Condition: Urinary Bladder, Overactive
Interventions: Drug: Mirabegron;   Drug: Tolterodine;   Drug: Placebo to Mirabegron;   Drug: Placebo to Tolterodine
9 Completed Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: tamoxifen citrate;   Radiation: radiation therapy
10 Completed ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: ISIS 5132
11 Completed Nexium Dyspepsia/AST
Conditions: Gastrointestinal Disease;   Signs and Symptoms, Digestive;   Dyspepsia
Intervention: Drug: Esomeprazole
12 Active, not recruiting The 36-month Extension to Follow up Sub Study
Conditions: Postphlebitic Syndrome;   Post-Thrombotic Syndrome;   Deep Vein Thrombosis
13 Completed
Has Results
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome
Conditions: Diabetes Mellitus, Type 2;   Acute Coronary Syndrome
Interventions: Drug: Alogliptin;   Drug: Placebo
14 Completed
Has Results
A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET)
Condition: Rheumatoid Arthritis
Intervention: Drug: rituximab
15 Recruiting Health Education Materials With or Without a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer
Conditions: Anxiety Disorder;   Cognitive/Functional Effects;   Colorectal Cancer;   Depression;   Fatigue;   Psychosocial Effects of Cancer and Its Treatment;   Sleep Disorders
Interventions: Behavioral: exercise intervention;   Other: counseling intervention;   Other: educational intervention;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: fatigue assessment and management;   Procedure: quality-of-life assessment
16 Completed Realities, Expectations and Attitudes to Life Support Technologies in Intensive Care for Octogenarians:
Condition: Critically Ill
17 Completed
Has Results
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: warfarin;   Drug: Dabigatran dose 1;   Drug: Dabigatran dose 2
18 Recruiting A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Conditions: Cancer;   Cataract;   Low Bone Mineral Density;   Osteopenia;   Osteoporosis;   Prostate Cancer
Interventions: Biological: Denosumab;   Biological: Placebo
19 Completed
Has Results
Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo identical to BI 10773 high dose;   Drug: Placebo identical to BI 10773 low dose;   Drug: BI 10773
20 Active, not recruiting Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Conditions: Myocardial Infarction;   Cardiovascular Death;   Atherothrombosis;   Stroke
Interventions: Drug: Ticagrelor 90 mg;   Drug: Ticagrelor 60 mg;   Drug: Ticagrelor Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years